L04AX Other immunosuppressants

PheWeb

RX_L04AX

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Medicine purchases: ATC L04AX

19287

Check pre-conditions, main-only, mode, ICD version None

15939

Check minimum number of events

Min. number of events 3

15939

Include endpoints None

15939

RX_L04AX

Extra metadata

First used in FinnGen datafreeze DF3

Similar endpoints

↥

List of similar endpoints to L04AX Other immunosuppressants based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	15470	9656	5814
Unadjusted prevalence (%)	5.01	5.56	4.31
Mean age at first event (years)	50.84	50.07	52.12

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.03	2.35 [1.86, 2.95]	3.3e-13	754
15 years	0.01	1.50 [1.20, 1.88]	3.6e-4	410
5 years	0.00	2.92 [2.38, 3.57]	2.9e-25	250
1 year	0.00	3.14 [2.28, 4.34]	3.3e-12	50

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: RX_L04AX – L04AX Other immunosuppressants
GWS hits:

Survival analyses between endpoints

↥

Plot

before L04AX Other immunosuppressants
after L04AX Other immunosuppressants

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after L04AX Other immunosuppressants

↥